Cite
MLA Citation
A. McMillan et al.. “P1189: INITIAL SAFETY RUN-IN RESULTS OF THE PHASE III POLARGO TRIAL: POLATUZUMAB VEDOTIN PLUS RITUXIMAB, GEMCITABINE, AND OXALIPLATIN IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA.” HemaSphere, vol. 6, n.d., pp. 1075–1076. http://access.bl.uk/ark:/81055/vdc_100159757491.0x000005